Mutation of Threonine 766 in the Epidermal Growth Factor Receptor Reveals a Hotspot for Resistance Formation against Selective Tyrosine Kinase Inhibitors
Open Access
- 1 April 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (17), 15435-15440
- https://doi.org/10.1074/jbc.m211158200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- STI571 (Gleevec™) as a paradigm for cancer therapyTrends in Molecular Medicine, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Rac/Cdc42 and p65PAK Regulate the Microtubule-destabilizing Protein Stathmin through Phosphorylation at Serine 16Published by Elsevier BV ,2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- A Grb2-associated docking protein in EGF- and insulin-receptor signallingNature, 1996
- Strain-Dependent Epithelial Defects in Mice Lacking the EGF ReceptorScience, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Protein modules and signalling networksNature, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- Signal transduction by receptors with tyrosine kinase activityCell, 1990